HUE033499T2 - Use of combination antimicrobials - Google Patents

Use of combination antimicrobials Download PDF

Info

Publication number
HUE033499T2
HUE033499T2 HUE07718439A HUE07718439A HUE033499T2 HU E033499 T2 HUE033499 T2 HU E033499T2 HU E07718439 A HUE07718439 A HU E07718439A HU E07718439 A HUE07718439 A HU E07718439A HU E033499 T2 HUE033499 T2 HU E033499T2
Authority
HU
Hungary
Prior art keywords
therapy
combination
vaginal
treatment
adhesion
Prior art date
Application number
HUE07718439A
Other languages
English (en)
Hungarian (hu)
Inventor
Christian Noe
Marion Noe-Letschnig
Original Assignee
Christian Noe
Marion Noe-Letschnig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Noe, Marion Noe-Letschnig filed Critical Christian Noe
Publication of HUE033499T2 publication Critical patent/HUE033499T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HUE07718439A 2006-05-12 2007-05-10 Use of combination antimicrobials HUE033499T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT8262006 2006-05-12

Publications (1)

Publication Number Publication Date
HUE033499T2 true HUE033499T2 (en) 2017-12-28

Family

ID=37903545

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE07718439A HUE033499T2 (en) 2006-05-12 2007-05-10 Use of combination antimicrobials

Country Status (19)

Country Link
US (2) US8552042B2 (enExample)
EP (2) EP3192507B1 (enExample)
JP (1) JP2009536926A (enExample)
CN (1) CN101484162A (enExample)
AU (1) AU2007250502B2 (enExample)
CA (1) CA2651726C (enExample)
CY (1) CY1119094T1 (enExample)
DK (1) DK2018164T3 (enExample)
ES (1) ES2627268T3 (enExample)
HR (1) HRP20170793T1 (enExample)
HU (1) HUE033499T2 (enExample)
LT (1) LT2018164T (enExample)
NO (2) NO342103B1 (enExample)
PL (1) PL2018164T3 (enExample)
PT (1) PT2018164T (enExample)
RS (1) RS56044B1 (enExample)
RU (1) RU2008148977A (enExample)
SI (1) SI2018164T1 (enExample)
WO (1) WO2007131253A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23311A (sl) * 2010-03-19 2011-09-30 Kemijski inštitut Farmacevtska kombinacija acetilsalicilne kisline in protiglivne substance za uničevanje ali inhibicijo rasti in replikacije gliv
CN102210649A (zh) * 2010-04-09 2011-10-12 上海医药科技发展有限公司 一种两性霉素b乳膏及其制备方法
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
CN103044408A (zh) * 2013-01-21 2013-04-17 万礼 在治疗恶性肿瘤时应用的伊曲康唑或其盐及其组合物
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
MX378376B (es) * 2015-01-13 2025-03-10 Acraf Composicion farmaceutica para el tratamiento de la micosis.
CN104920360B (zh) * 2015-06-18 2017-04-12 青岛农业大学 丁苯羟酸在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的用途
EP3482743A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur behandlung von scheideninfektionen
PL3709969T3 (pl) * 2017-11-14 2024-02-19 Profem Gmbh Emulsje do miejscowego leczenia zakażeń skóry i śluzówek
EP3482744A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
US20250302821A1 (en) * 2022-05-12 2025-10-02 St. Jude Children's Research Hospital, Inc. Synergistic antifungal composition and method
WO2024187210A1 (de) 2023-03-15 2024-09-19 Profem Gmbh Kombinationsarzneimittel zur behandlung und reduktion der rückfallraten vaginaler mykosen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6471823A (en) * 1987-09-12 1989-03-16 Rohto Pharma Sustained remedy for vaginal candidiasis
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ES2079994B1 (es) 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
CA2177683C (en) * 1993-12-23 1999-12-28 George Endel Deckner Tissue moisturizing and antimicrobial compositions
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
WO2000048633A1 (en) 1999-02-19 2000-08-24 Ligocyte Pharmaceuticals, Inc. Antibodies against hydrophobic proteins that are protective against candidiasis
DK1191939T3 (da) 1999-03-24 2008-02-11 Zengen Inc Antimikrobielle aminosyresekvenser afledt fra alfa-melanocytstimulerende hormon
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040142910A1 (en) * 2002-10-21 2004-07-22 Aegis Biosciences Llc Sulfonated styrene copolymers for medical uses
AU2003293529A1 (en) * 2002-12-16 2004-07-29 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
US20070099932A1 (en) 2003-06-25 2007-05-03 Toshihiro Shirouzu External preparation for athlete's foot treatment
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
CA2567803A1 (en) * 2004-05-28 2005-12-15 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole

Also Published As

Publication number Publication date
DK2018164T3 (en) 2017-06-12
NO20180083A1 (no) 2009-02-10
RS56044B1 (sr) 2017-09-29
WO2007131253A2 (de) 2007-11-22
US8552042B2 (en) 2013-10-08
NO20085181L (no) 2009-02-10
AU2007250502B2 (en) 2013-11-28
JP2009536926A (ja) 2009-10-22
CA2651726C (en) 2015-12-15
US20140030312A1 (en) 2014-01-30
PT2018164T (pt) 2017-06-12
EP2018164A2 (de) 2009-01-28
CY1119094T1 (el) 2018-01-10
CA2651726A1 (en) 2007-11-22
PL2018164T3 (pl) 2017-08-31
EP3192507B1 (de) 2020-07-08
NO342103B1 (no) 2018-03-26
SI2018164T1 (sl) 2017-07-31
RU2008148977A (ru) 2010-06-20
AU2007250502A1 (en) 2007-11-22
US20090208558A1 (en) 2009-08-20
NO345064B1 (no) 2020-09-14
CN101484162A (zh) 2009-07-15
EP3192507A1 (de) 2017-07-19
ES2627268T3 (es) 2017-07-27
US8815925B2 (en) 2014-08-26
WO2007131253A3 (de) 2008-11-27
HRP20170793T1 (hr) 2017-10-06
LT2018164T (lt) 2017-07-10
EP2018164B1 (de) 2017-03-01

Similar Documents

Publication Publication Date Title
HUE033499T2 (en) Use of combination antimicrobials
RU2533458C2 (ru) Композиции, содежащие берберин или его аналоги для лечения кожных заболеваний, связанных с розацеа или с покраснением лица
US9662360B2 (en) Treatment of herpes, pseudomonas, staph, and hepatitis
WO2019130215A1 (en) Cannabis compositions for the treatment of inflammatory skin disorders
JP5872673B2 (ja) 皮膚疾患を治療するための方法
US20240366550A1 (en) Drug for Treating Prostatitis or Benign Prostatic Hyperplasia (BPH)
US11439631B2 (en) Use of a glutarimide derivative to treat diseases related to the aberrant activity of cytokines
CN111135141A (zh) 一种鼻腔用复合水凝胶制备方法
RU2358744C1 (ru) Способ лечения онихомикоза
AU2017261517B2 (en) Use of combination preparations, comprising antimycotics
CN114366732B (zh) 泰妙菌素在制备用于治疗银屑病的药物中的应用
RU2789515C1 (ru) Фармацевтическая композиция на основе аквакомплекса глицеросольвата титана в сочетании с L-аргинином для лечения воспалительных заболеваний слизистой оболочки полости рта
CN120437267A (zh) 沙丁鱼肽组合物在制备防治唇炎的药物中的新用途
AU2013254945A1 (en) Use of combination preparations, comprising antimycotics
RU2147440C1 (ru) Обезболивающее и противозудное средство
RU2321395C1 (ru) Способ лечения больных акантолитической пузырчаткой
WO2023220396A1 (en) Methods of treatment using a dual specificity tyrosine-phosphorylation-regulated kinase 1a (dyrk1a) inhibitor
CN116036105A (zh) 一种治疗淋巴水肿的药物运用
TW202448432A (zh) 肌萎縮性側索硬化症（ａｌｓ）的治療
US20090247498A1 (en) Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications
EP0293529A1 (en) Admixtures of diflunisal and tromethamine
CN101703504A (zh) 一种阴道用药物组合物
HK1092693B (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
UA74090C2 (en) Use of amison for treating eczematous lesions
CN1751681A (zh) 治疗慢性鼻窦炎的阿司咪唑新剂型